Contents 2 min read

Claim and source comparison

Melatonin: primary sleep disorders, jet lag, prolonged release and safety.

· Bounded source comparison; not a complete clinical review or independent medical endorsement.

Systematic review / meta-analysis

Ferracioli-Oda et al. (2013) pooled 19 studies and 1683 participants: sleep onset was about 7 minutes shorter, total sleep about 8 minutes longer, and sleep quality improved modestly. This analysis does not establish that tolerance never occurs.

Different primary sleep disorders were pooled. A small average improvement does not establish the same benefit for everyone or long-term safety.

Source 2 · Full text read

Systematic review / meta-analysis

In 8 of the Cochrane review’s 10 trials, melatonin reduced jet lag after flights crossing at least 5 time zones.

The older review studied travel settings and specific timing. It does not establish the same result for chronic insomnia, shift work or a personal schedule.

Source 4 · Official summary read

Human pharmacokinetic study

The Circadin 2 mg prolonged-release product information reports a terminal half-life of 3.5–4 hours.

This duration is product-specific. It cannot be applied as one decay curve to immediate-release preparations or all melatonin products.

Source 5 · Official summary read

Official safety summary

NIH NCCIH notes insufficient long-term safety data. People with epilepsy and those taking blood thinners need medical supervision when using melatonin.

Pregnancy and breastfeeding research is limited. Headache, dizziness, nausea and sleepiness have been reported. Risk varies by product and person.

Source 6 · Official summary read

Our evidence and source methodology

melatonin: conceptual editorial illustration
Conceptual editorial artwork; not a research finding or evidence of clinical benefit in humans.

What is Melatonin?

Melatonin (N-acetyl-5-methoxytryptamine) is a hormone produced by the pineal gland in the brain and secreted in response to darkness. By giving a "night" signal to the body's internal clock, it regulates the sleep-wake cycle, i.e. circadian rhythm regulates.

Melatonin, synthesized from serotonin, is suppressed by light exposure; Therefore, blue light emitted from screens in the evening can delay natural secretion. As a supplement, melatonin is used to externally strengthen this signal.

Clinical Evidence

Brzezinski et al. (2005) pooled 17 studies and 284 participants, finding sleep onset 4 minutes shorter and total sleep 12.8 minutes longer. These small average changes do not establish a powerful sleep treatment for everyone.

Ferracioli-Oda et al. (2013) pooled 19 studies and 1683 participants: sleep onset was about 7 minutes shorter, total sleep about 8 minutes longer, and sleep quality improved modestly. This analysis does not establish that tolerance never occurs.

In 8 of the Cochrane review’s 10 trials, melatonin reduced jet lag after flights crossing at least 5 time zones.

Dose information and research limits

Melatonin dose and timing depend on the indication and formulation. A higher dose is not always better, and universal superiority of low doses is unproven. Incorrect timing in circadian disorders may shift the clock in the wrong direction; a personal plan needs professional guidance.

Dose information and research limits

This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

The Circadin 2 mg prolonged-release product information reports a terminal half-life of 3.5–4 hours.

This duration is product-specific. It cannot be applied as one decay curve to immediate-release preparations or all melatonin products.

Safety and Side Effects

NIH NCCIH notes insufficient long-term safety data. People with epilepsy and those taking blood thinners need medical supervision when using melatonin.

Pregnancy and breastfeeding research is limited. Headache, dizziness, nausea and sleepiness have been reported. Risk varies by product and person.

Related research and reading

These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.

Educational guides

Sources

  1. Brzezinski A, et al. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9(1), 41–50. PubMed · PMID 15649737
  2. Ferracioli-Oda E, Qawasmi A, Bloch MH. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773. PubMed · PMID 23691095
  3. Auld F, et al. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews, 34, 10–22. PubMed · PMID 28648359
  4. Herxheimer A, Petrie KJ. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, (2), CD001520. PubMed · PMID 12076414
  5. Flynn Pharma. Circadin 2 mg Prolonged-release Tablets: Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/2809/smpc Flynn Pharma / electronic medicines compendium
  6. NIH NCCIH. Melatonin: What You Need To Know. https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know NIH NCCIH

Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory

Frequently Asked Questions